Literature DB >> 34819330

Risk of adverse events and reported clinical relapse after COVID-19 vaccination in patients with IBD.

Rosanna Cannatelli1, Francesca Ferretti2, Stefania Carmagnola2, Irene Maria Bambina Bergna2, Maria Camilla Monico2, Giovanni Maconi2, Sandro Ardizzone2.   

Abstract

Entities:  

Keywords:  COVID-19; adverse drug reactions; inflammatory bowel disease

Mesh：

Substances：

Year:  2021        PMID： 34819330     DOI： 10.1136/gutjnl-2021-326237

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   31.793


× No keyword cloud information.
  3 in total

1.  Impact of BNT162b2 mRNA Vaccination on the Development of Short and Long-Term Vaccine-Related Adverse Events in Inflammatory Bowel Disease: A Multi-Center Prospective Study.

Authors:  Mohammad Shehab; Fatema Alrashed; Israa Abdullah; Ahmad Alfadhli; Hamad Ali; Mohamed Abu-Farha; Arshad Mohamed Channanath; Jehad Ahmed Abubaker; Fahd Al-Mulla
Journal:  Front Med (Lausanne)       Date:  2022-06-08

2.  Real-World Use and Adverse Events of SARS-CoV-2 Vaccination in Greek Patients with Inflammatory Bowel Disease.

Authors:  Eleni Orfanoudaki; Eirini Zacharopoulou; Vassiliki Kitsou; Konstantinos Karmiris; Angeliki Theodoropoulou; Gerassimos J Mantzaris; Maria Tzouvala; Spyridon Michopoulos; Evanthia Zampeli; Georgios Michalopoulos; Pantelis Karatzas; Nikos Viazis; Christos Liatsos; Giorgos Bamias; Ioannis E Koutroubakis
Journal:  J Clin Med       Date:  2022-01-27       Impact factor: 4.241

3.  Effectiveness and safety of SARS-CoV-2 vaccine in Inflammatory Bowel Disease patients: a systematic review, meta-analysis and meta-regression.

Authors:  Abhishek Bhurwal; Hemant Mutneja; Vikas Bansal; Akshay Goel; Shilpa Arora; Bashar Attar; Carlos D Minacapelli; Gursimran Kochhar; Lea Ann Chen; Steve Brant; Darren Seril
Journal:  Aliment Pharmacol Ther       Date:  2022-03-30       Impact factor: 9.524
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.